GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a truly shift in how we treat type 2 diabetes . These new drugs work by stimulating the body’s own GLP-1 substance , which promotes https://mysocialguides.com/story7248269/glp-1-a-significant-approach-in-diabetes-treatment